Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
In this paper we study the application of a single drug in cancer chemotherapy where the drug can block progression through the cell cycle. Under certain conditions we determine the regimen that reduces the tumor population to a desired endpoint in minimal time while keeping a normal cell population above some lower limit. We also study the sensitivity of the optimal solution to various parameters.